ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ALLR Allarity Therapeutics Inc

1.14
-0.09 (-7.32%)
최종 업데이트: 23:15:13
15분 지연
기업명 주식 심볼 시장 주식 타입
Allarity Therapeutics Inc ALLR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.09 -7.32% 1.14 23:15:13
개장가 저가 고가 종가 전일 종가
1.20 1.10 1.23 1.23
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202421:00GLOBEAllarity Therapeutics’ Stenoparib Shows Clear Clinical..
29/04/202420:00GLOBEAllarity Therapeutics Regains Compliance with NASDAQ Minimum..
17/04/202422:10GLOBEAllarity Therapeutics Receives NASDAQ-Approved Extension to..
04/04/202422:15GLOBEAllarity Therapeutics Announces 1-for-20 Reverse Stock Split
27/03/202421:30GLOBEAllarity Therapeutics Makes Strategic Pivot to Focus Solely..
25/03/202420:30GLOBEAllarity Therapeutics Receives Extension from Nasdaq..
08/03/202422:38EDGAR2Form 8-K - Current report
08/03/202421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/03/202421:15GLOBEAllarity Therapeutics Reports Full Year 2023 Financial..
08/03/202411:45EDGAR2Form DEF 14A - Other definitive proxy statements
05/03/202406:05EDGAR2Form 8-K - Current report
01/03/202423:21EDGAR2Form 8-K - Current report
28/02/202420:00GLOBEAllarity Therapeutics to Present at Biomarkers 2024
24/02/202406:09EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14/02/202423:03EDGAR2Form 8-K - Current report
03/02/202407:03EDGAR2Form D - Notice of Exempt Offering of Securities
02/02/202406:40EDGAR2Form 8-K - Current report
27/01/202407:07EDGAR2Form PRE 14A - Other preliminary proxy statements
26/01/202407:24EDGAR2Form 8-K - Current report
20/01/202407:29EDGAR2Form 8-K - Current report
16/12/202307:00EDGAR2Form S-1/A - General form for registration of securities..
12/12/202320:00GLOBEAllarity Therapeutics Announces Thomas Jensen as Interim CEO..
11/12/202320:30EDGAR2Form 8-K - Current report
07/12/202307:00EDGAR2Form 8-K - Current report
06/12/202322:30EDGAR2Form S-1/A - General form for registration of securities..
05/12/202321:30EDGAR2Form 8-K - Current report
05/12/202321:30GLOBEAllarity’s Early Phase 2 Stenoparib Data Indicates Clinical..
18/11/202307:01EDGAR2Form 8-K - Current report
13/11/202322:35EDGAR2Form 8-K - Current report
03/11/202306:00EDGAR2Form S-3 - Registration statement under Securities Act of..
31/10/202322:30EDGAR2Form S-1 - General form for registration of securities under..
31/10/202306:00EDGAR2Form 8-K - Current report
24/10/202306:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/10/202306:00EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/10/202306:00EDGAR2Form S-3 - Registration statement under Securities Act of..
02/10/202320:00GLOBEAllarity Therapeutics to Present at Biomarkers Europe 2023
28/09/202305:30EDGAR2Form 8-K - Current report
15/09/202321:45EDGAR2Form 8-K - Current report
31/08/202305:05GLOBEPLOS ONE Publishes Data on Allarity Therapeutics’ DRP®..
15/08/202304:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202321:15EDGAR2Form 8-K - Current report
31/07/202319:00GLOBEAllarity Therapeutics and FivepHusion Announce Collaboration..
28/07/202305:01EDGAR2Form 8-K - Current report
24/07/202319:00GLOBEAllarity Therapeutics Strengthens Board of Directors with..
18/07/202306:10EDGAR2Form 8-K - Current report
12/07/202305:05EDGAR2Form 8-K - Current report
08/07/202305:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
06/07/202319:05EDGAR2Form 8-K - Current report
06/07/202319:00GLOBEAllarity Therapeutics, Inc. Announces Pricing of $11 Million..
06/07/202305:31EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock